The Journal of Clinical Psychiatry

Page 194

More JCP Articles

Original Research

Predictors of the Impact of Nonpharmacologic Interventions for Agitation in Nursing Home Residents With Advanced Dementia

July 25, 2014

Jiska Cohen-Mansfield , Khin Thein , Marcia S. Marx

Article

Prescription Drug Monitoring Program Inquiry in Psychiatric Assessment: Detection of High Rates of Opioid Prescribing to a Dual Diagnosis Population

July 25, 2014

Daniel T. Hackman , Marion S. Greene , Taya J. Fernandes , et al

Book Review

Professionalism in Psychiatry

July 25, 2014

Joel Yager

Original Research

Risk of Suicidal Behavior With Antidepressants in Bipolar and Unipolar Disorders

July 25, 2014

Andrew C. Leon , Jess G. Fiedorowicz , David A. Solomon , et al

ASCP Corner

Whatever Happened to New Treatments for Alzheimer’s Disease?

July 25, 2014

Davangere P. Devanand

Original Research

Dose Reduction of Risperidone and Olanzapine and Estimated Dopamine D2 Receptor Occupancy in Stable Patients With Schizophrenia: Findings From an Open-Label, Randomized, Controlled Study

July 22, 2014

Hiroyoshi Takeuchi , Takefumi Suzuki , Robert R. Bies , et al

Original Research

Efficacy and Safety of Adjunctive Armodafinil in Adults With Major Depressive Episodes Associated With Bipolar I Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial

July 22, 2014

Joseph R. Calabrese , Mark A. Frye , Ronghua Yang , et al

Educational Activity

Current Standards of Treatment in MS and the Role of Oral Agents

July 15, 2014

Harold Moses, Jr

Educational Activity

Emerging Trends: Novel Molecular Targets and Moving Beyond Acute Symptoms in Bipolar Depression

July 15, 2014

Eduard Vieta

Educational Activity

The Glutamate Hypothesis of Schizophrenia

July 15, 2014

Jonathan M. Meyer

Original Research

Appetite Regulatory Hormones in Women With Anorexia Nervosa: Binge-Eating/Purging Versus Restricting Type

July 8, 2014

Kamryn T. Eddy , Elizabeth A. Lawson , Christina Meade , et al

Review Article

Cognitive Effects of Pharmacotherapy for Major Depressive Disorder: A Systematic Review

July 8, 2014

Richard S. E. Keefe , Shawn M. McClintock , Robert M. Roth , et al

« 1 … 192 193 194 195 196 … 757 »

Predictors of the Impact of Nonpharmacologic Interventions for Agitation in Nursing Home Residents With Advanced Dementia

Prescription Drug Monitoring Program Inquiry in Psychiatric Assessment: Detection of High Rates of Opioid Prescribing to a Dual Diagnosis Population

Professionalism in Psychiatry

Risk of Suicidal Behavior With Antidepressants in Bipolar and Unipolar Disorders

Whatever Happened to New Treatments for Alzheimer’s Disease?

Dose Reduction of Risperidone and Olanzapine and Estimated Dopamine D2 Receptor Occupancy in Stable Patients With Schizophrenia: Findings From an Open-Label, Randomized, Controlled Study

Efficacy and Safety of Adjunctive Armodafinil in Adults With Major Depressive Episodes Associated With Bipolar I Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial

Current Standards of Treatment in MS and the Role of Oral Agents

Emerging Trends: Novel Molecular Targets and Moving Beyond Acute Symptoms in Bipolar Depression

The Glutamate Hypothesis of Schizophrenia

Appetite Regulatory Hormones in Women With Anorexia Nervosa: Binge-Eating/Purging Versus Restricting Type

Cognitive Effects of Pharmacotherapy for Major Depressive Disorder: A Systematic Review

ELSEWHERE:

FOLLOW US:

More JCP Articles

Predictors of the Impact of Nonpharmacologic Interventions for Agitation in Nursing Home Residents With Advanced Dementia

Prescription Drug Monitoring Program Inquiry in Psychiatric Assessment: Detection of High Rates of Opioid Prescribing to a Dual Diagnosis Population

Professionalism in Psychiatry

Risk of Suicidal Behavior With Antidepressants in Bipolar and Unipolar Disorders

Whatever Happened to New Treatments for Alzheimer’s Disease?

Dose Reduction of Risperidone and Olanzapine and Estimated Dopamine D2 Receptor Occupancy in Stable Patients With Schizophrenia: Findings From an Open-Label, Randomized, Controlled Study

Efficacy and Safety of Adjunctive Armodafinil in Adults With Major Depressive Episodes Associated With Bipolar I Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial

Current Standards of Treatment in MS and the Role of Oral Agents

Emerging Trends: Novel Molecular Targets and Moving Beyond Acute Symptoms in Bipolar Depression

The Glutamate Hypothesis of Schizophrenia

Appetite Regulatory Hormones in Women With Anorexia Nervosa: Binge-Eating/Purging Versus Restricting Type

Cognitive Effects of Pharmacotherapy for Major Depressive Disorder: A Systematic Review

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles